News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
724,339 Results
Type
Article (41347)
Company Profile (272)
Press Release (682708)
Multimedia
Podcasts (82)
Webinars (18)
Section
Business (205283)
Career Advice (2044)
Deals (35617)
Drug Delivery (112)
Drug Development (81576)
Employer Resources (178)
FDA (16497)
Job Trends (14986)
News (347431)
Policy (32816)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2591)
Accelerated approval (31)
Adcomms (24)
Allergies (138)
Alliances (49744)
ALS (168)
Alzheimer's disease (1664)
Antibody-drug conjugate (ADC) (306)
Approvals (16759)
Artificial intelligence (506)
Autoimmune disease (148)
Automation (37)
Bankruptcy (362)
Best Places to Work (11670)
BIOSECURE Act (20)
Biosimilars (188)
Biotechnology (178)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (634)
Cancer (4765)
Cardiovascular disease (400)
Career advice (1728)
Career pathing (35)
CAR-T (277)
CDC (44)
Celiac Disease (2)
Cell therapy (732)
Cervical cancer (36)
Clinical research (69646)
Collaboration (1685)
Company closure (4)
Compensation (1155)
Complete response letters (52)
COVID-19 (2713)
CRISPR (87)
C-suite (820)
Cystic fibrosis (143)
Data (6178)
Decentralized trials (2)
Denatured (27)
Depression (130)
Diabetes (499)
Diagnostics (6698)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (245)
Drug pricing (186)
Drug shortages (28)
Duchenne muscular dystrophy (228)
Earnings (90209)
Editorial (55)
Employer branding (22)
Employer resources (154)
Events (117623)
Executive appointments (965)
FDA (19587)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1450)
Gene editing (191)
Generative AI (42)
Gene therapy (589)
GLP-1 (965)
Government (4668)
Grass and pollen (6)
Guidances (383)
Healthcare (18944)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (245)
Immuno-oncology (55)
Indications (104)
Infectious disease (2973)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (243)
Interviews (322)
IPO (16659)
IRA (49)
Job creations (3654)
Job search strategy (1442)
JPM (58)
Kidney cancer (16)
Labor market (84)
Layoffs (547)
Leadership (30)
Legal (7972)
Liver cancer (91)
Longevity (14)
Lung cancer (641)
Lymphoma (372)
Machine learning (42)
Management (60)
Manufacturing (779)
MASH (162)
Medical device (13845)
Medtech (13897)
Mergers & acquisitions (20015)
Metabolic disorders (1258)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (309)
Neuropsychiatric disorders (86)
Neuroscience (2877)
Neurotech (1)
NextGen: Class of 2026 (6538)
Non-profit (4526)
Now hiring (65)
Obesity (590)
Opinion (259)
Ovarian cancer (164)
Pain (198)
Pancreatic cancer (222)
Parkinson's disease (279)
Partnered (34)
Patents (490)
Patient recruitment (475)
Peanut (56)
People (59058)
Pharmaceutical (63)
Pharmacy benefit managers (29)
Phase 1 (21720)
Phase 2 (30651)
Phase 3 (22827)
Pipeline (5130)
Policy (278)
Postmarket research (2574)
Preclinical (9233)
Press Release (64)
Prostate cancer (234)
Psychedelics (47)
Radiopharmaceuticals (277)
Rare diseases (821)
Real estate (5982)
Recruiting (71)
Regulatory (24487)
Reports (53)
Research institute (2401)
Resumes & cover letters (353)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (146)
Series A (239)
Series B (185)
Service/supplier (11)
Sickle cell disease (96)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3633)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (84)
The Weekly (53)
Vaccines (984)
Venture capital (87)
Weight loss (379)
Women's health (87)
Worklife (18)
Date
Today (93)
Last 7 days (569)
Last 30 days (2043)
Last 365 days (29914)
2026 (2920)
2025 (30265)
2024 (35298)
2023 (40190)
2022 (51278)
2021 (55831)
2020 (54248)
2019 (46743)
2018 (35139)
2017 (32262)
2016 (31637)
2015 (37730)
2014 (31478)
2013 (26546)
2012 (28762)
2011 (29436)
2010 (27511)
Location
Africa (740)
Alabama (83)
Alaska (7)
Arizona (306)
Arkansas (13)
Asia (39446)
Australia (6445)
California (11197)
Canada (3258)
China (1089)
Colorado (475)
Connecticut (471)
Delaware (332)
Europe (85178)
Florida (1669)
Georgia (353)
Hawaii (3)
Idaho (62)
Illinois (859)
India (62)
Indiana (516)
Iowa (22)
Japan (422)
Kansas (125)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1373)
Massachusetts (8022)
Michigan (319)
Minnesota (624)
Mississippi (5)
Missouri (127)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (79)
New Jersey (2973)
New Mexico (28)
New York (2954)
North Carolina (1439)
North Dakota (8)
Northern California (5464)
Ohio (331)
Oklahoma (21)
Oregon (41)
Pennsylvania (2260)
Puerto Rico (22)
Rhode Island (47)
South America (1115)
South Carolina (65)
South Dakota (1)
Southern California (4351)
Tennessee (172)
Texas (1726)
United States (39697)
Utah (334)
Vermont (1)
Virginia (256)
Washington D.C. (81)
Washington State (916)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
724,339 Results for "vascular dynamics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Revance and Teoxane Announce the FDA Approval of RHA® Dynamic Volume for Midface Contour Deficiencies
January 14, 2026
·
10 min read
Press Releases
Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025
November 24, 2025
·
3 min read
Press Releases
Aquedeon Medical Inc. Receives FDA Approval to Expand Clinical Trial of Duett Vascular Graft System
August 13, 2025
·
2 min read
Press Releases
Hemostemix Appoints Renowned Vascular Surgeon and Principal Investigator, Dr. York Hsiang, as Business Consultant to Advance First Nations-Led Healthcare Partnerships
February 3, 2026
·
1 min read
Press Releases
Dr. William R. Shankle to Advance ACP-01 as a Treatment for Vascular Dementia
November 20, 2025
·
9 min read
Press Releases
Cloudbreak Pharma Inc. Announces Positive Phase 2 Results for CBT-004 in Patients with Vascularized Pinguecula
July 21, 2025
·
5 min read
Press Releases
Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Diseases and Vascular Malformations with No FDA-Approved Therapies
January 9, 2026
·
14 min read
Press Releases
Grace Therapeutics Announces Abstract Accepted for Presentation at Society of Vascular and Interventional Neurology Annual Meeting
November 11, 2025
·
3 min read
Press Releases
Clinical Data on Effect of Sotagliflozin on Adipose Distribution in Non-Diabetic Patients will be Presented at the 2025 Cardio Vascular Clinical Trialists Forum
December 8, 2025
·
4 min read
Press Releases
Feinstein Institutes’ Research Pinpoints Core Cause of Vascular Cognitive Impairment, Unlocking New Therapeutic Avenues for Cognitive Decline
December 8, 2025
·
3 min read
1 of 72,434
Next
